
Sign up to save your podcasts
Or


Steve Gruber is joined by Dr. Peter McCullough, Chief Scientific Officer at The Wellness Company, to discuss a groundbreaking new study suggesting chemotherapy might reactivate dormant cancer cells, and what that means for patients. They dive into Big Pharma’s reluctance to explore low-cost alternatives, the emerging potential of ivermectin as a cancer treatment, and practical advice for parasite cleansing and protecting against the spike in tick bites this year.
Visit twc.health/GRUBER, Promo Code GRUBER Saves 10%.
By Steve Gruber4.5
9494 ratings
Steve Gruber is joined by Dr. Peter McCullough, Chief Scientific Officer at The Wellness Company, to discuss a groundbreaking new study suggesting chemotherapy might reactivate dormant cancer cells, and what that means for patients. They dive into Big Pharma’s reluctance to explore low-cost alternatives, the emerging potential of ivermectin as a cancer treatment, and practical advice for parasite cleansing and protecting against the spike in tick bites this year.
Visit twc.health/GRUBER, Promo Code GRUBER Saves 10%.

23,356 Listeners

26,464 Listeners

12,091 Listeners

64,567 Listeners

41,393 Listeners

10,200 Listeners

2,052 Listeners

5,659 Listeners

65,964 Listeners

6,566 Listeners

43,953 Listeners

6,923 Listeners

8,433 Listeners

2,308 Listeners

1,827 Listeners